Exact Mass: 468.2182
Exact Mass Matches: 468.2182
Found 500 metabolites which its exact mass value is equals to given mass value 468.2182
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Henatinib
Ruboxistaurin
1,2-Dihydro-8-hydroxyisopentanyl-2-methoxy-4-O-methylalpinumisoflavone
1,2-Dihydro-8-hydroxyisopentanyl-3-methoxy-4-O-methylalpinumisoflavone
lomerizine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
3,5-dihydroxy-6-methyl-octanoic acid 5-O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinofuranoside|5-O-alpha-L-rhamnopyranosyl-(1 -> 2)-alpha-L-arabinofuranosyl 3,5-dihydroxy-6-methyl-octanoic acid
6-O-(beta-D-glucopyranosyl)-1-O-octanoyl-beta-D-glucopyranose|6-O-beta-D-glucopyranosyl-1-O-octanoyl-beta-D-glucopyranose|nonioside C
17-acetoxy-1-acetyl-10,11-dimethoxy-4-methyl-3,4-seco-cura-18,20-dien-3-one|Strychnosilin|Strychnosiline
Me glycoside,hexa-Me,6-Me ester-2-O-beta-D-Glucopyranuranuronosyl-D-mannose
(1S,4S,5R,7R,9S,10S)-9-benzoyloxy-1-(3-furoyloxy)-4-hydroxy-dihydro-beta-agarofuran
2-O-(beta-D-glucopyranosyl)-1-O-octanoyl-beta-D-glucopyranose
17-defurano-17-(2,5-dihydro-2-oxofuran-3-yl)-28-deoxonimbolide|methyl (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cS)-8-(2,5-dihydro-2-oxo-3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-5-oxo-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-bc]difuran-6-acetate
5,3?-dihydroxy-7,4?-dimethoxy-6,8-dimethylallyl-2,3-dihydroflavonol|prenyl-isotirumalin
3-(2-hydroxypropyl)-9-(3-hydroxy-6,8-dimethyldeca-2,4,6-trienoyl)-(6aR)-6a-methyl-9,9a-dihydro-6aH-furo[2,3-h]isochromene-6,8-dione|sassafrin A
Ala Cys Ile Tyr
Ala Cys Leu Tyr
Ala Cys Tyr Ile
Ala Cys Tyr Leu
Ala Phe Met Thr
Ala Phe Thr Met
Ala His Asn Gln
Ala His Gln Asn
Ala Ile Cys Tyr
Ala Ile Tyr Cys
Ala Leu Cys Tyr
Ala Leu Tyr Cys
Ala Met Phe Thr
Ala Met Thr Phe
Ala Asn His Gln
Ala Asn Gln His
Ala Gln His Asn
Ala Gln Asn His
Ala Thr Phe Met
Ala Thr Met Phe
Ala Tyr Cys Ile
Ala Tyr Cys Leu
Ala Tyr Ile Cys
Ala Tyr Leu Cys
Cys Ala Ile Tyr
Cys Ala Leu Tyr
Cys Ala Tyr Ile
Cys Ala Tyr Leu
Cys Phe Ile Ser
Cys Phe Leu Ser
Cys Phe Ser Ile
Cys Phe Ser Leu
Cys Phe Thr Val
Cys Phe Val Thr
Cys His Ile Pro
Cys His Leu Pro
Cys His Pro Ile
Cys His Pro Leu
Cys Ile Ala Tyr
Cys Ile Phe Ser
Cys Ile His Pro
Cys Ile Pro His
Cys Ile Ser Phe
Cys Ile Tyr Ala
Cys Leu Ala Tyr
Cys Leu Phe Ser
Cys Leu His Pro
Cys Leu Pro His
Cys Leu Ser Phe
Cys Leu Tyr Ala
Cys Pro His Ile
Cys Pro His Leu
Cys Pro Ile His
Cys Pro Leu His
Cys Ser Phe Ile
Cys Ser Phe Leu
Cys Ser Ile Phe
Cys Ser Leu Phe
Cys Thr Phe Val
Cys Thr Val Phe
Cys Val Phe Thr
Cys Val Thr Phe
Cys Tyr Ala Ile
Cys Tyr Ala Leu
Cys Tyr Ile Ala
Cys Tyr Leu Ala
Phe Ala Met Thr
Phe Ala Thr Met
Phe Cys Ile Ser
Phe Cys Leu Ser
Phe Cys Ser Ile
Phe Cys Ser Leu
Phe Cys Thr Val
Phe Cys Val Thr
Phe Ile Cys Ser
Phe Ile Ser Cys
Phe Leu Cys Ser
Phe Leu Ser Cys
Phe Met Ala Thr
Phe Met Thr Ala
Phe Ser Cys Ile
Phe Ser Cys Leu
Phe Ser Ile Cys
Phe Ser Leu Cys
Phe Thr Ala Met
Phe Thr Cys Val
Phe Thr Met Ala
Phe Thr Thr Thr
Phe Thr Val Cys
Phe Val Cys Thr
Phe Val Thr Cys
Gly His Gln Gln
Gly Met Val Tyr
Gly Met Tyr Val
Gly Gln His Gln
Gly Gln Gln His
Gly Val Met Tyr
Gly Val Tyr Met
Gly Tyr Met Val
Gly Tyr Val Met
His Ala Asn Gln
His Ala Gln Asn
His Cys Ile Pro
His Cys Leu Pro
His Cys Pro Ile
His Cys Pro Leu
His Gly Gln Gln
His Ile Cys Pro
His Ile Pro Cys
His Leu Cys Pro
His Leu Pro Cys
His Asn Ala Gln
His Asn Gln Ala
His Pro Cys Ile
His Pro Cys Leu
His Pro Ile Cys
His Pro Leu Cys
His Gln Ala Asn
His Gln Gly Gln
His Gln Asn Ala
His Gln Gln Gly
Ile Ala Cys Tyr
Ile Ala Tyr Cys
Ile Cys Ala Tyr
Ile Cys Phe Ser
Ile Cys His Pro
Ile Cys Pro His
Ile Cys Ser Phe
Ile Cys Tyr Ala
Ile Phe Cys Ser
Ile Phe Ser Cys
Ile His Cys Pro
Ile His Pro Cys
Ile Pro Cys His
Ile Pro His Cys
Ile Ser Cys Phe
Ile Ser Phe Cys
Ile Ser Ser Tyr
Ile Ser Tyr Ser
Ile Tyr Ala Cys
Ile Tyr Cys Ala
Ile Tyr Ser Ser
Leu Ala Cys Tyr
Leu Ala Tyr Cys
Leu Cys Ala Tyr
Leu Cys Phe Ser
Leu Cys His Pro
Leu Cys Pro His
Leu Cys Ser Phe
Leu Cys Tyr Ala
Leu Phe Cys Ser
Leu Phe Ser Cys
Leu His Cys Pro
Leu His Pro Cys
Leu Pro Cys His
Leu Pro His Cys
Leu Ser Cys Phe
Leu Ser Phe Cys
Leu Ser Ser Tyr
Leu Ser Tyr Ser
Leu Tyr Ala Cys
Leu Tyr Cys Ala
Leu Tyr Ser Ser
Met Ala Phe Thr
Met Ala Thr Phe
Met Phe Ala Thr
Met Phe Thr Ala
Met Gly Val Tyr
Met Gly Tyr Val
Met Thr Ala Phe
Met Thr Phe Ala
Met Val Gly Tyr
Met Val Tyr Gly
Met Tyr Gly Val
Met Tyr Val Gly
Asn Ala His Gln
Asn Ala Gln His
Asn His Ala Gln
Asn His Gln Ala
Asn Gln Ala His
Asn Gln His Ala
Pro Cys His Ile
Pro Cys His Leu
Pro Cys Ile His
Pro Cys Leu His
Pro His Cys Ile
Pro His Cys Leu
Pro His Ile Cys
Pro His Leu Cys
Pro Ile Cys His
Pro Ile His Cys
Pro Leu Cys His
Pro Leu His Cys
Gln Ala His Asn
Gln Ala Asn His
Gln Gly His Gln
Gln Gly Gln His
Gln His Ala Asn
Gln His Gly Gln
Gln His Asn Ala
Gln His Gln Gly
Gln Asn Ala His
Gln Asn His Ala
Gln Gln Gly His
Gln Gln His Gly
Ser Cys Phe Ile
Ser Cys Phe Leu
Ser Cys Ile Phe
Ser Cys Leu Phe
Ser Phe Cys Ile
Ser Phe Cys Leu
Ser Phe Ile Cys
Ser Phe Leu Cys
Ser Ile Cys Phe
Ser Ile Phe Cys
Ser Ile Ser Tyr
Ser Ile Tyr Ser
Ser Leu Cys Phe
Ser Leu Phe Cys
Ser Leu Ser Tyr
Ser Leu Tyr Ser
Ser Ser Ile Tyr
Ser Ser Leu Tyr
Ser Ser Tyr Ile
Ser Ser Tyr Leu
Ser Thr Val Tyr
Ser Thr Tyr Val
Ser Val Thr Tyr
Ser Val Tyr Thr
Ser Tyr Ile Ser
Ser Tyr Leu Ser
Ser Tyr Ser Ile
Ser Tyr Ser Leu
Ser Tyr Thr Val
Ser Tyr Val Thr
Thr Ala Phe Met
Thr Ala Met Phe
Thr Cys Phe Val
Thr Phe Thr Thr
Thr Ser Val Tyr
Thr Ser Tyr Val
Thr Thr Phe Thr
Thr Thr Thr Phe
Thr Val Ser Tyr
Thr Val Tyr Ser
Thr Tyr Ser Val
Thr Tyr Val Ser
Val Ser Thr Tyr
Val Ser Tyr Thr
Val Thr Phe Cys
Val Thr Ser Tyr
Val Thr Tyr Ser
Val Tyr Gly Met
Val Tyr Met Gly
Val Tyr Ser Thr
Val Tyr Thr Ser
Tyr Ala Cys Ile
Tyr Ala Cys Leu
Tyr Ala Ile Cys
Tyr Ala Leu Cys
Tyr Cys Ala Ile
Tyr Cys Ala Leu
Tyr Cys Ile Ala
Tyr Cys Leu Ala
Tyr Gly Met Val
Tyr Gly Val Met
Tyr Ile Ala Cys
Tyr Ile Cys Ala
Tyr Ile Ser Ser
Tyr Leu Ala Cys
Tyr Leu Cys Ala
Tyr Leu Ser Ser
Tyr Met Gly Val
Tyr Met Val Gly
Tyr Ser Ile Ser
Tyr Ser Leu Ser
Tyr Ser Ser Ile
Tyr Ser Ser Leu
Tyr Ser Thr Val
Tyr Ser Val Thr
Tyr Thr Ser Val
Tyr Thr Val Ser
Tyr Val Gly Met
Tyr Val Met Gly
Tyr Val Ser Thr
Tyr Val Thr Ser
Ruboxistaurin
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors
METHYL 3-(((2-CYCLOPENTYL-6,7-DIMETHYL-1-OXO-2,3-DIHYDRO-1H-INDEN-5-YL)OXY)METHYL)-[1,1-BIPHENYL]-4-CARBOXYLATE
2,2-METHYLENEBIS[6-(2-HYDROXY-5-METHYLBENZYL)-P-CRESOL]
(R)-(+)-2,2-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6-dimethoxy-1,1-biphenyl,min.
beta-D-Fructofuranosyl 6-O-octanoyl-alpha-D-glucopyranoside
(1S,12R,23R)-16-acetyl-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetrazahexacyclo[12.10.0.02,11.04,9.015,23.017,22]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione
2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-hydroxy-5-phosphonopentanoic acid
2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-5-(2-hydroxy-3-morpholin-4-ylpropyl)-3-methyl-1,6,7,8-tetrahydropyrrolo[3,2-c]azepin-4-one
1-[3-Methyl-1-[1-[(4-methylphenyl)sulfonylmethyl]-5-tetrazolyl]butyl]-4-phenylpiperazine
1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(4-fluorophenyl)-1-[2-(1-pyrrolidinyl)ethyl]urea
2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
Leu-Ser-Ser-Tyr
A tetrapeptide composed of L-leucine, two L-serine units and L-tyrosine joined in sequence by peptide linkages.
3-[(4R,5R)-4-carbamoyl-2-[4-(3-hydroxypropoxy)phenyl]-5-phenyl-5H-oxazol-4-yl]propanoic acid tert-butyl ester
2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
N-[(1S,3S,4aS,9aR)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
[(1S)-1-(hydroxymethyl)-7-methoxy-1-(phenylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-3-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
[(8R,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(2-methylphenyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(1R)-1-(hydroxymethyl)-7-methoxy-1-(phenylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
BAY-3827
BAY-3827 is a potent and selective AMPK inhibitor with IC50 values of 1.4 nM at low (10 μM ATP concentration) and 15 nM at high (2 mM ATP concentration). BAY-3827 shows over 500-fold selectivity for most of the 331 kinases. BAY-3827 prevents phosphorylation of acetyl-CoA carboxylase 1 and shows strongest anti-proliferative activity in androgen-dependent prostate cancer cell lines[1].